RxDoctor Payments Data

Patricia Ferro

Primary Care · Havertown, PANPI 1346006889

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations.

$2,160in general payments, 2019–2025

Across 97 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$263
  • Novo Nordisk$245
  • Shield Therapeutics Inc$208
  • GSK$184
  • Lilly USA, LLC$171
  • Otsuka America Pharmaceutical, Inc.$171
  • plus $919 from 21 others

What the payments were for

  • Food & beverage$2,160100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,160 in reported general payments places this provider in the 80th percentile of 300 primary care providers in Pennsylvania.

See all primary care providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$21,408
Medicare patients
182
Services billed
408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium32$521
Albuterol Sulfate HfaAlbuterol Sulfate14$384
Levetiracetam16$356
Fluticasone Propionate29$348
Rosuvastatin Calcium11$340
Omeprazole17$316
Escitalopram Oxalate17$273
Metformin Hcl16$249
Valsartan16$221
Amlodipine Besylate30$206
Azithromycin39$147
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$142
Atorvastatin Calcium22$133
Losartan Potassium12$127
Ibuprofen11$96

Paid to pharmacies, not to this prescriber.

Other primary care in Havertown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →